BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 29
• 30
• 31

• Mettler-Toledo Release: Less Waste, Lower Costs: Optimizing Enzymatic Catalysis With in Situ Reaction Analysis

  May 7, 2012

   · 

  2 min read
• Policy

  Grant & Eisenhofer Represents Lead Whistleblower in Historic $1.6 Billion Settlement With Abbott Laboratories Over Off-Label Marketing of Antiepileptic Medication Depakote

  May 7, 2012

   · 

  5 min read
• Biotech Bay

  Talon Therapeutics, Inc. Receives Notification of Three Month PDUFA Date Extension for Marqibo(R)

  May 7, 2012

   · 

  4 min read
• Nuvo Research Inc.'s Pliaglis Receives Positive Opinion from the BfArM in the E.U.

  May 7, 2012

   · 

  5 min read
• Drug Development

  Dainippon Sumitomo Pharma Co., Ltd. Reports that Latuda® (lurasidone HCl) Met Primary and Key Secondary Endpoints in Two Phase III Trials in Bipolar I Depression

  May 7, 2012

   · 

  16 min read
• Drug Development

  Kythera Biopharmaceuticals Announces Presentation of Positive Results from First of Two ATX-101 European Phase III Trials for Reduction of Submental Fat

  May 7, 2012

   · 

  6 min read
• Biotech Bay

  Kerberos to Sell FDA Cleared Rinspiration Technology

  May 7, 2012

   · 

  2 min read
• Policy

  Bayer AG Challenges Nexavar Generic Licence Order

  May 7, 2012

   · 

  1 min read
• Drug Development

  PROLOR Biotech Announces Top-Line Results from Four-Month Treatment Extension of its Long-Acting Human Growth Hormone Phase II Trial

  May 7, 2012

   · 

  6 min read
• Genetown

  Syracuse Basketball Icon Jim Boeheim Joins Cellceutix to Fight Cancer

  May 7, 2012

   · 

  5 min read